Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

AstraZeneca PLC (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11,591.000 +39.000    +0.34%
03/02 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 52
  • Bid/Ask: 11,534.000 / 11,591.000
  • Day's Range: 11,574.000 - 11,740.000
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT112489 
AstraZeneca 11,591.000 +39.000 +0.34%

AstraZeneca PLC Company Profile

 
Read the Astrazeneca company profile to learn more about the business and the management team. View employee data, company address and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

83100

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.

Top Executives

Name Age Since Title
Euan A. Ashley 49 2020 Independent Non-Executive Director
Diana Layfield 50 2020 Independent Non-Executive Director
Leif Johansson 70 2012 Independent Non-Executive Chairman
Pascal Soriot 62 2012 CEO & Executive Director
Philip Arthur John Broadley 60 2017 Senior Independent Non-Executive Director
Katarina Ageborg - 2011 EVP of Sustainability, Chief Compliance Officer & Member of External Sustainability Advisory Board
Pam P. Cheng 50 2015 EVP of Operations & Information Technology and Member of External Sustainability Advisory Board
Polly Courtice 69 - Member of External Sustainability Advisory Board
Rain Henderson - - Member of External Sustainability Advisory Board
Pankaj Bhatia - - Member of External Sustainability Advisory Board
Louise Nicholls - - Member of External Sustainability Advisory Board
Andreas Rummelt 66 2021 Independent Non-Executive Director
Aradhana Sarin 47 2021 CFO & Executive Director
Menelas Pangalos - 2013 EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board
Jeffrey Pott - 2009 Chief Human Resources Officer, General Counsel & Member of External Sustainability Advisory Board
Marcus Wallenberg 66 1999 Non-Executive Director
Nazneen Rahman 54 2017 Independent Non-Executive Director
Michel Demare 66 2019 Independent Non-Executive Director
Sherilyn S. D. McCoy 63 2017 Independent Non-Executive Director
Deborah DiSanzo Eldracher 62 2017 Independent Non-Executive Director
Shu Kam Mok 61 2019 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Vijay Deep
Vijay Deep Jan 12, 2023 3:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Md Raihan Khan
Md Raihan Khan Dec 08, 2022 22:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If I don't know anything about this job now, please tell me everything
Rizwan Biag
Rizwan Biag Oct 15, 2022 19:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rizwan baig
Aug 23, 2022 16:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't shorts from technical analysis informa will move from 11,158 to 11345.4 today target 🎯so buy quickly. don't short. if downtrend going then strongly buy.
Aug 23, 2022 15:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't shorts from analysis AZN will move from now 11,158 today target 11345.78 easily movement🎯so buy quickly.
You We
You We Jul 26, 2022 23:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
iam new don't know anything doesnt even have a bank account can someone help?
Youser Al sayah
Youser Al sayah Jul 26, 2022 23:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get a bank account
Skhulile Sakhi
Skhulile Sakhi Jun 01, 2022 14:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi I'm new here please help
Samuel Mankiwe
Samuel Mankiwe May 02, 2022 16:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm happy to trade with you
Ali Faizan
Ali Faizan Mar 17, 2022 12:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good.., are you free
Om Ar
Om Ar Mar 17, 2022 12:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeh I am..
Ramakrishna Nekkanti
Ramakrishna Nekkanti Feb 10, 2022 11:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just buy and hold it as long as u can
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email